Category : Search result: weightloss drugs


Novo Nordisk cuts forecasts again as drug demand slows

Danish pharmaceutical giant Novo Nordisk has cut its sales and profit forecasts for the second time in three months, sending shockwaves through the healthcare sector as demand for its blockbuster weight-loss drugs shows signs of slowing.

Gear-ly Beloved: Drug Crisis Hits UK Weddings

Exclusive investigation reveals rising substance abuse at British weddings, from cocaine in bathrooms to MDMA on dance floors. Discover the highs, lows and sobering reality.

Novo Nordisk Bids for Metsera, Challenging Pfizer's Offer

Danish pharmaceutical giant Novo Nordisk has entered a bidding war with Pfizer for obesity-focused biotech firm Metsera, potentially disrupting the US company's planned acquisition in a major power play for obesity treatment dominance.

Page 1 of 1